A Systematic Review and Meta-analysis of Subsequent Malignant Neoplasm Risk after Radioactive Iodine Treatment of Thyroid Cancer.
CONCLUSIONS: The body of evidence on whether I-131 treatment of thyroid cancer is associated with the primary outcome of any SMN is highly heterogeneous and complex. More research is needed examining the long-term risk of specific SMNs after I-131 treatment.
PMID: 30370820 [PubMed - as supplied by publisher]
Source: Thyroid : official journal of the American Thyroid Association - Category: Endocrinology Tags: Thyroid Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Databases & Libraries | Endocrinology | Hematology | Iodine | Leukemia | Myeloma | Statistics | Study | Thyroid | Thyroid Cancer